Another advantage to buying ETFs instead of individual stocks is you avoid some reporting requirements, due to conflict of interest concerns. For example, NIH financial CoI requires me to disclose all individual stocks/companies/financial compensation over $5000 or over a set % ownership. However, the guidelines exempt funds where I don't choose the specific companies, and can't sell them off.
It's not usually a big deal for large caps (mostly aimed at limiting pharma CoIs), but it saves time spent on the paperwork, and if you like the privacy.
Passive ETF ownership is a way around a lot of requirements. With ETFs getting imore and more niched down, you can still get the exposure you want too.
Another advantage to buying ETFs instead of individual stocks is you avoid some reporting requirements, due to conflict of interest concerns. For example, NIH financial CoI requires me to disclose all individual stocks/companies/financial compensation over $5000 or over a set % ownership. However, the guidelines exempt funds where I don't choose the specific companies, and can't sell them off.
It's not usually a big deal for large caps (mostly aimed at limiting pharma CoIs), but it saves time spent on the paperwork, and if you like the privacy.
Good addition.
Passive ETF ownership is a way around a lot of requirements. With ETFs getting imore and more niched down, you can still get the exposure you want too.
Yup! Just have to make sure the ETF price tracks what it claims to track instead of the S&P or Dow.